ClinicalTrials.gg
Not yet recruitingNCT07933003Prehab-COGUpdated Nov 12, 2026

Prehab-COG: Does Preoperative Exercise Improve Postoperative Cognitive Outcomes?

An interventional study of Tailored exercise program in Cognition, Postoperative Delirium and Preoperative Aerobic Training, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Stanford University · Not applicable, Interventional, and Prevention

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 81 studies in Emergence Delirium with a site in United States — 19 open to participants now, 20 under way, 2 of them phase 3. Emergence Delirium · United States.

Planned enrollment
58th of 65
15 · median 100
Started
2027
with 1 other
No phase
30 of 81
9 open now
Primary completion
2027-06
later than 7 of 19 live
Registered
81st of 81
by date
Lead sponsor
5 of 81
Stanford University

Among the 81 studies in Emergence Delirium with a site in United States, this one is the 58th largest by planned enrollment of the 65 interventional ones that give a count, is one of 2 that started in 2027, is one of 30 with no phase, reaches primary completion later than 7 of the 19 other live ones, and was the 81st registered.

Emergence Delirium

751 studies on the registry are indexed under Emergence Delirium; 262 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

19 of the 81 studies in Emergence Delirium with a site in United States are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 143 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 45 (31%) stop at 75 or younger; 35 take children under 18; 25 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Emergence Delirium with a site in United States, or all of them as a file.
02

Study summary

The purpose of this protocol is to evaluate the feasibility and acceptability of a preoperative exercise intervention (Prehabilitation) program, along with intraoperative Electroencephalography (EEG) recordings, and pre and post operative cognitive testing in older patients undergoing a major surgery.

03

Conditions studied

  • Cognition
  • Postoperative Delirium
  • Preoperative Aerobic Training
  • EEG
  • Prehabilitation

Browse trials for

Keywords

  • Prehabilitation
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults patients (50 years old or older).
  2. Scheduled to undergo non-cardiac or non-neurological surgery under general anesthesia.
  3. Plan to be admitted to the hospital after surgery for a minimum of one night.
  4. classification I to III.
  5. English or Spanish fluency (Cognitive testing only validated to be used with English or Spanish speakers).

Exclusion criteria

Exclusion Criteria:

  1. Not able to understand/speak English or Spanish
  2. Failure to satisfy adequate hearing test with/without hearing aids.
  3. Visual impairment.
  4. Unplanned ICU admission after surgery.
  5. Patients who are undergoing another intervention study that consists of a cognitive or exercise intervention.
  6. Inability to provide consistent EEG data of sufficient quality, determined at enrollment.
  7. Subjects with medical conditions including but not limited to: Angina pectoris, Congestive Heart Failure (CHF) that make it dangerous for unsupervised physical activity, cognitive and psychiatric conditions that may affect ability to consent.
  8. Subjects who have to unsupervised exercise including but not limited to fall risks, movement disorders, and those who are on ambulatory oxygen therapy.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Moderate Exercise Arm

    The participants will undergo the virtual exercise intervention 2xweek for 3-4 weeks prior to surgery, and take cognitive testing with non-invasive EEG recordings at 5-point time (the baseline prior to start of the exercise program, at 2-4 days prior to surgery, during the surgery, post-op, and 30-day post surgery). Participants will also be interviewed after the intervention and after surgery to obtain their feedback on their experience with the study procedures.

    Behavioral: Tailored exercise program

Interventions

  • BehavioralTailored exercise program

    Eligible participants will receive their exercise program, relevant informational material and training. The exercise program will be tailored to the physical fitness of the participants. The 2xweek virtual sessions take 30 minutes each and include guided exercises at mild-moderate intensity.

06

What researchers measure

Primary outcomes

  1. Evaluate the feasibility of a preoperative home-based exercise intervention program, with intraoperative EEG recording, and pre and post operative cognitive testing, among older patients undergoing major surgery.

    Feasibility will be measured by: 1. Proportion of Eligible Patients Approached Who Enrolled (Number of eligible patients who enrolled divided by the number of eligible patients approached) 2. Proportion of Enrolled Participants Completing All Planned Study Data-Collection Assessments (Number and the percentage of the completion for each of the planned data collection points)

    Time frame: Maximum 3 months from participant enrollment to end/completion of all study-related tasks.

  2. Evaluate the acceptability of a preoperative home-based exercise intervention program, with intraoperative EEG recording, and pre and post operative cognitive testing, among older patients undergoing major surgery.

    Acceptability will be measured by: 1\) Aggregated (mean) Score of Surveyed Participants' Rating Across Each Study-Task (Average score of participants' ratings across study tasks, including exercise program, EEG recording and cognitive testing).

    Time frame: Maximum 3 months from participant enrollment to end/completion of all study-related tasks.

07

Study locations

1 site
  • Stanford Healthcare Centers
    Stanford, California 94305, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jun 2027, 5 months later.

Of 184 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 5 months is below that.

Counting every sponsor, half of 184 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2026
First posted
Nov 12, 2026
StartEst.
Jan 2027
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07933003
Responsible party
Cindy Kin (Associate Professor of Medicine, Stanford University) — Principal investigator
First posted
Nov 12, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Cindy Kin, MD
study director · Stanford University
Patrick Purdon, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion